Who can benefit more from its twelve-week treatment: A prospective cohort study of blonanserin for patients with schizophrenia

Bao-Yan Xu, Kun Jin, Hai-Shan Wu, Xue-Jun Liu, Xi-Jin Wang, Hong Sang, Ke-Qing Li, Mei-Juan Sun, Hua-Qing Meng, Huai-Li Deng, Zhi-Yuan Xun, Xiao-Dong Yang, Lin Zhang, Guan-Jun Li, Rui-Ling Zhang, Duan-Fang Cai, Jia-Hong Liu, Gui-Jun Zhao, Long-Fa Liu, Gang Wang, Chang-Lie Zhao, Bin Guo, Sheng-Chun J · 2024

Read Who can benefit more from its twelve-week treatment: A prospective cohort study of blonanserin for patients with schizophrenia by Bao-Yan Xu, Kun Jin, Hai-Shan Wu, Xue-Jun Liu, Xi-Jin Wang, Hong Sang, Ke-Qing Li, Mei-Juan Sun, Hua-Qing Meng, Huai-Li Deng, Zhi-Yuan Xun, Xiao-Dong Yang, Lin Zhang, Guan-Jun Li, Rui-Ling Zhang, Duan-Fang Cai, Jia-Hong Liu, Gui-Jun Zhao, Long-Fa Liu, Gang Wang, Chang-Lie Zhao, Bin Guo, Sheng-Chun J (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11572666.txt.

Description

Bao-Yan Xu and co-authors ask which schizophrenia patients benefit most from a drug called blonanserin in a 2024 study. The drug is known as effective and well tolerated. A twelve week, open, multi center surveillance study followed more than three thousand patients after marketing. Rating scale scores measured benefit, and adverse reactions measured safety.

Scores fell markedly over twelve weeks. Movement side effects were the most common adverse reaction. Analysis found several factors shaped score gains, including illness phase, starting score, episode length, and prior episodes. Patients in an acute phase, with higher starting scores, a short current episode, and few prior episodes gained the most. Readers see a profile of the best responders to guide prescribing.

Catalog record

CREATORBao-Yan Xu, Kun Jin, Hai-Shan Wu, Xue-Jun Liu, Xi-Jin Wang, Hong Sang, Ke-Qing Li, Mei-Juan Sun, Hua-Qing Meng, Huai-Li Deng, Zhi-Yuan Xun, Xiao-Dong Yang, Lin Zhang, Guan-Jun Li, Rui-Ling Zhang, Duan-Fang Cai, Jia-Hong Liu, Gui-Jun Zhao, Long-Fa Liu, Gang Wang, Chang-Lie Zhao, Bin Guo, Sheng-Chun J
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11572666

Browse the full library · About the Tower of Babel